Clinical Trial Update: Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing neoadjuvant trastuzumab and pertuzumab with concurrent taxane chemotherapy or endocrine therapy in operable HER2+/HR+ breast cancer, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms

Drugs mentioned

• Endocrine therapy
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)
• taxane chemotherapy (taxane)

Snippet

Sponsor: Palleos Healthcare GmbH | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED